Cancers, Vol. 10, Pages 504: Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases

Cancers, Vol. 10, Pages 504: Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases

Cancers doi: 10.3390/cancers10120504

Authors: Pauline Roussille Gaelle Tachon Claire Villalva Serge Milin Eric Frouin Julie Godet Antoine Berger Sheik Emambux Christos Petropoulos Michel Wager Lucie Karayan-Tapon David Tougeron

Background: Colorectal cancers (CRC) with brain metastases (BM) are scarcely described. The main objective of this study was to determine the molecular profile of CRC with BM. Methods: We included 82 CRC patients with BM. KRAS, NRAS, BRAF and mismatch repair (MMR) status were investigated on primary tumors (n = 82) and BM (n = 38). ALK, ROS1, cMET, HER-2, PD-1, PD-L1, CD3 and CD8 status were evaluated by immunohistochemistry, and when recommended, by fluorescence in situ hybridization. Results: In primary tumors, KRAS, NRAS and BRAF mutations were observed in 56%, 6%, and 6% of cases, respectively. No ROS1, ALK and cMET rearrangement was detected. Only one tumor presented HER-2 amplification. Molecular profiles were mostly concordant between BM and paired primary tumors, except for 9% of discordances for RAS mutation. CD3, CD8, PD-1 and PD-L1 expressions presented some discordance between primary tumors and BM. In multivariate analysis, multiple BM, lung metastases and PD-L1+ tumor were predictive of poor overall survival. Conclusions: CRCs with BM are associated with high frequency of RAS mutations and significant discordance for RAS mutational status between BM and paired primary tumors. Multiple BM, lung metastases and PD-L1+ have been identified as prognostic factors and can guide therapeutic decisions for CRC patients with BM.

https://ift.tt/2rwQV5O